Cargando…
Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies
In contemporary oncology practices there is an increasing emphasis on concurrent evaluation of multiple genomic alterations within the biological pathways driving tumorigenesis. At the foundation of this paradigm shift are several commercially available tumor panels using next-generation sequencing...
Autores principales: | Marrone, Michael, Filipski, Kelly K, Gillanders, Elizabeth M, Schully, Sheri D, Freedman, Andrew N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038678/ https://www.ncbi.nlm.nih.gov/pubmed/24904755 http://dx.doi.org/10.1371/currents.eogt.aa5415d435fc886145bd7137a280a971 |
Ejemplares similares
-
Use of Oncotype DX in Women with Node-Positive Breast Cancer
por: Ishibe, Naoko, et al.
Publicado: (2011) -
Use of Epidermal Growth Factor Receptor Mutation Analysis in Patients with Advanced Non-Small-Cell Lung Cancer to Determine Erlotinib Use as First-Line Therapy
por: Ishibe, Naoko, et al.
Publicado: (2011) -
Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test
por: Ned, Renée M., et al.
Publicado: (2011) -
HLA-B*5701 testing to predict abacavir hypersensitivity
por: Ma, Joseph D., et al.
Publicado: (2010) -
Oncotype DX tumor gene expression profiling in stage II colon cancer: Application: Prognostic, risk prediction
por: Webber, Elizabeth M., et al.
Publicado: (2010)